These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10210300)

  • 1. Mirtazapine and the granulocytes--so far so good.
    Meyboom RH; Edwards IR; Egberts AC
    N Z Med J; 1999 Mar; 112(1084):104. PubMed ID: 10210300
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arthralgia associated with mirtazapine].
    Veyrac G; Brachet V; Rocher S; Bourin M; Jolliet P
    Therapie; 2000; 55(5):652-5. PubMed ID: 11201983
    [No Abstract]   [Full Text] [Related]  

  • 3. Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia.
    Anghelescu I; Klawe C; Dahmen N
    J Clin Psychiatry; 2002 Sep; 63(9):838. PubMed ID: 12363126
    [No Abstract]   [Full Text] [Related]  

  • 4. Repeated angioedema following administration of venlafaxine and mirtazapine.
    Lin CE; Chen CL
    Gen Hosp Psychiatry; 2010; 32(3):341.e1-2. PubMed ID: 20430242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine.
    Weber-Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Kopf D; Lederbogen F; Deuschle M
    J Clin Psychopharmacol; 2008 Oct; 28(5):581-4. PubMed ID: 18794665
    [No Abstract]   [Full Text] [Related]  

  • 6. Sertraline- and mirtazapine-induced severe neutropenia.
    Ozcanli T; Unsalver B; Ozdemir S; Ozmen M
    Am J Psychiatry; 2005 Jul; 162(7):1386. PubMed ID: 15994730
    [No Abstract]   [Full Text] [Related]  

  • 7. Mianserin, agranulocytosis, and suicide.
    Thomas CS; Read DA
    Lancet; 1990 Dec; 336(8729):1511. PubMed ID: 1979118
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfer of the antidepressant mirtazapine into breast milk.
    Kristensen JH; Ilett KF; Rampono J; Kohan R; Hackett LP
    Br J Clin Pharmacol; 2007 Mar; 63(3):322-7. PubMed ID: 16970569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of mirtazapine: revisited.
    Davis J; Barkin RL
    Am Fam Physician; 1999 Sep; 60(4):1101. PubMed ID: 10507741
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirtazapine-induced hyponatraemia.
    Roxanas MG
    Med J Aust; 2003 Oct; 179(8):453-4. PubMed ID: 14558878
    [No Abstract]   [Full Text] [Related]  

  • 13. Mirtazapine-induced akathisia.
    Gulsun M; Doruk A
    J Clin Psychopharmacol; 2008 Aug; 28(4):467. PubMed ID: 18626283
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse reactions to mirtazapine are unlikely to be serotonin toxicity.
    Isbister GK; Whyte IM
    Clin Neuropharmacol; 2003; 26(6):287-8; author reply 289-90. PubMed ID: 14646603
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute reversible dyskinesia induced by mirtazapine.
    Konitsiotis S; Pappa S; Mantas C; Mavreas V
    Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
    [No Abstract]   [Full Text] [Related]  

  • 16. Newer antidepressants in pregnancy: prospective outcome of a case series.
    Yaris F; Kadioglu M; Kesim M; Ulku C; Yaris E; Kalyoncu NI; Unsal M
    Reprod Toxicol; 2004 Dec; 19(2):235-8. PubMed ID: 15501389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine: unable to induce serotonin toxicity?
    Gillman PK
    Clin Neuropharmacol; 2003; 26(6):288-9; author reply 289-90. PubMed ID: 14646604
    [No Abstract]   [Full Text] [Related]  

  • 18. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
    Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible mirtazapine-induced rhabdomyolysis.
    Khandat AB; Nurnberger JI; Shekhar A
    Ann Pharmacother; 2004; 38(7-8):1321. PubMed ID: 15187213
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurologic oral manifestations caused by a new formulation of mirtazapine.
    Kling A; Dahlqvist R; Johansson S; Bäckström M; Mjörndal T
    Neurology; 2005 Jul; 65(2):333-4. PubMed ID: 16043818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.